Research output per year
Research output per year
Fingerprint
Dive into the research topics where Helene Broch Tenstad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma
Tenstad, H. B., Ruhlmann, C. H., Möller, S., Kjaer, S., Bastholt, L., Just, S. A. & Lindegaard, H., Mar 2025, In: Journal of Autoimmunity. 152, 7 p., 103400.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile3 Downloads (Pure) -
Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small-cell lung cancer
Mikkelsen, A. W., Nilsson, A. C., Tenstad, H. B., Lillevang, S. T. & Asgari, N., Jun 2024, In: Thoracic Cancer. 15, 17, p. 1350-1356Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile37 Downloads (Pure) -
Vaccination af patienter med reumatologiske lidelser
Colic, A., Sørensen, C. M., Schreiber, K., Dreyer, L. W., Larsen, L. H., Broch Tenstad, H. & Hendricks, O., 2024Research output: Other contribution › Net publication - Internet publication › Commissioned › peer-review
Open Access -
Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy
Jensen, A. K., Chatzidionysiou, K., Torp, C. K., Sørensen, A. S., Tenstad, H. B., Schäfer, V. S., Kostine, M., Jacobsen, S., Leipe, J. & Kragstrup, T. W., Apr 2022, In: Biomedicine & Pharmacotherapy. 148, 9 p., 112687.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile94 Downloads (Pure) -
Prediction and early diagnosis of immune-checkpoint inhibitor-induced inflammatory arthritis from molecular biomarkers – Where are we now?
Aboo, C., Krastrup, T. W., Tenstad, H. B., Ren, J., Just, S. A., Ladekarl, M. & Stensballe, A., 2022, In: Expert Review of Precision Medicine and Drug Development. 7, 1, p. 162-168Research output: Contribution to journal › Journal article › Research › peer-review
Press/Media
-
Folk med autoimmune gigtsygdomme kommer for sent i behandling
19/11/2024
1 Media contribution
Press/Media: Press / Media
-
Kan vi forudsige, hvilke kræftpatienter der får leddegigt som bivirkning af immunterapi?
09/05/2023
1 Media contribution
Press/Media: Press / Media